• CESTEM1B: Phase IB dose escalation trail in head and neck, triple negative breast and adenoid cystic cancers.
  • Improving ADCC response in monoclonal antibody therapy using dynamin inhibition.
  • Characterising the protein complexes responsible for immune synapse formation to allow rational drug design to modulate immunity both as increase and decrease.

Student projects available

  • Identifying natural killer cell memory response antigens in therapy context
  • Characterisation of cell biology and signalling biogenesis of the immune synapse